Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2005-6-9
pubmed:abstractText
The 2-phenylnaphthalene scaffold was explored as a simplified version of genistein in order to identify ER selective ligands. With the aid of docking studies, positions 1, 4, and 8 of the 2-phenylnaphthalene template were predicted to be the most potentially influential positions to enhance ER selectivity using two different binding orientations. Both orientations have the phenol moiety mimicking the A-ring of genistein. Several compounds predicted to adopt orientations similar to that of genistein when bound to ERbeta were observed to have slightly higher ER affinity and selectivity than genistein. The second orientation we exploited, which was different from that of genistein when bound to ERbeta, resulted in the discovery of several compounds that had superior ER selectivity and affinity versus genistein. X-ray structures of two ER selective compounds (i.e., 15 and 47) confirmed the alternate binding mode and suggested that substituents at positions 1 and 8 were responsible for inducing selectivity. One compound (i.e., 47, WAY-202196) was further examined and found to be effective in two models of inflammation, suggesting that targeting ER may be therapeutically useful in treating certain chronic inflammatory diseases.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0022-2623
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
48
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3953-79
pubmed:meshHeading
pubmed-meshheading:15943471-Animals, pubmed-meshheading:15943471-Animals, Genetically Modified, pubmed-meshheading:15943471-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:15943471-Arthritis, Experimental, pubmed-meshheading:15943471-Binding Sites, pubmed-meshheading:15943471-Cell Line, Tumor, pubmed-meshheading:15943471-Crystallography, X-Ray, pubmed-meshheading:15943471-Estrogen Receptor beta, pubmed-meshheading:15943471-Female, pubmed-meshheading:15943471-Genistein, pubmed-meshheading:15943471-Humans, pubmed-meshheading:15943471-Inflammatory Bowel Diseases, pubmed-meshheading:15943471-Ligands, pubmed-meshheading:15943471-Male, pubmed-meshheading:15943471-Models, Molecular, pubmed-meshheading:15943471-Molecular Conformation, pubmed-meshheading:15943471-Molecular Mimicry, pubmed-meshheading:15943471-Molecular Structure, pubmed-meshheading:15943471-Naphthalenes, pubmed-meshheading:15943471-Naphthols, pubmed-meshheading:15943471-Organ Size, pubmed-meshheading:15943471-Rats, pubmed-meshheading:15943471-Rats, Inbred Lew, pubmed-meshheading:15943471-Structure-Activity Relationship, pubmed-meshheading:15943471-Transcription, Genetic, pubmed-meshheading:15943471-Uterus
pubmed:year
2005
pubmed:articleTitle
ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.
pubmed:affiliation
Chemical and Screening Sciences, Wyeth Research, Collegeville, Pennsylvania 19426, USA. mewshar@wyeth.com
pubmed:publicationType
Journal Article